Cargando…

Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study

INTRODUCTION: Several monoclonal antibodies (mAbs) have been linked to neuropsychiatric adverse effects in patients, including depression and suicidal ideation and behavior. OBJECTIVE: The aim of this study was to quantify and characterize spontaneously reported adverse drug reactions (ADRs) of depr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minnema, Lotte A., Giezen, Thijs J., Souverein, Patrick C., Egberts, Toine C. G., Leufkens, Hubert G. M., Gardarsdottir, Helga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581921/ https://www.ncbi.nlm.nih.gov/pubmed/30617497 http://dx.doi.org/10.1007/s40264-018-00789-9

Ejemplares similares

Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF‐α Inhibitors
por: Minnema, Lotte A., et al.
Publicado: (2020)

Post‐marketing dosing changes in the label of biologicals
por: Minnema, Lotte A., et al.
Publicado: (2019)

Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
por: Willemen, Marjolein J., et al.
Publicado: (2011)

Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase
por: Man, Wai Hong, et al.
Publicado: (2020)

Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars
por: Alsamil, Ali M., et al.
Publicado: (2021)

VigiAccess: Promoting public access to VigiBase
por: Shankar, Pathiyil Ravi
Publicado: (2016)

Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the scientific community
por: Minnema, L. A., et al.
Publicado: (2020)

Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase(®)
por: Vogel, Ulrich, et al.
Publicado: (2020)

Montelukast and Nightmares: Further Characterisation Using Data from VigiBase
por: Watson, Sarah, et al.
Publicado: (2022)

Infections associated with clozapine: a pharmacovigilance study using VigiBase(®)
por: Chrétien, Basile, et al.
Publicado: (2023)

Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites
por: Juhlin, Kristina, et al.
Publicado: (2015)

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Switching TNFα inhibitors: Patterns and determinants
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Characterization of VigiBase reports on tinnitus associated with bisoprolol—An exploratory and descriptive study
por: Watson, Sarah, et al.
Publicado: (2021)

Ocular surface disorders associated with the use of dupilumab based on WHO VigiBase
por: Park, Sunny, et al.
Publicado: (2021)

Short communication: Comments on hair disorders associated with dupilumab based on VigiBase
por: Park, Sunny, et al.
Publicado: (2022)

The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase(®)
por: Matlala, Mafora F., et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase(®) Spontaneous Reporting System
por: Noseda, Roberta, et al.
Publicado: (2022)

Cyclo‐oxygenase selectivity and chemical groups of nonsteroidal anti‐inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase
por: Bakhriansyah, Mohammad, et al.
Publicado: (2019)

Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase(®)
por: Chandler, Rebecca E., et al.
Publicado: (2016)

Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase(®)
por: Sessa, Maurizio, et al.
Publicado: (2019)

Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020
por: Rocca, Elena, et al.
Publicado: (2021)

Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines
por: Dutta, Siddhartha, et al.
Publicado: (2022)

A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders
por: Huruba, Madalina, et al.
Publicado: (2022)

Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar
por: Meijboom, Rosanne W., et al.
Publicado: (2023)

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase(®)
por: Ampadu, Haggar H., et al.
Publicado: (2016)

Valproic Acid and Fatalities in Children: A Review of Individual Case Safety Reports in VigiBase
por: Star, Kristina, et al.
Publicado: (2014)

Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre
por: Star, Kristina, et al.
Publicado: (2019)

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
por: Garcia, Philippe, et al.
Publicado: (2020)

Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase
por: Noseda, Roberta, et al.
Publicado: (2021)

Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase
por: Zhang, Qingxia, et al.
Publicado: (2022)

Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database
por: Pochet, Stéphanie, et al.
Publicado: (2022)

Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill Criteria
por: Yue, Qun-Ying, et al.
Publicado: (2022)

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database
por: Mhaidat, Nizar Mahmoud, et al.
Publicado: (2023)

Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
por: Calapai, Fabrizio, et al.
Publicado: (2023)

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
por: Gastaldon, C., et al.
Publicado: (2023)

Pre-Existing Cardiovascular Conditions as Clinical Predictors of Myocarditis Reporting with Immune Checkpoint Inhibitors: A VigiBase Study
por: Noseda, Roberta, et al.
Publicado: (2020)

Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBase
por: Noseda, Roberta, et al.
Publicado: (2021)

A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders
por: Huruba, Madalina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u0grojfakheim7p1o1eue35044